Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Giloralimab (ABBV-927), an agonistic monoclonal antibody targeting CD40, exhibits potent activity and is being investigated for potential application in cancer research [1] [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry | |
5 mg | Inquiry | Inquiry |
Description | Giloralimab (ABBV-927), an agonistic monoclonal antibody targeting CD40, exhibits potent activity and is being investigated for potential application in cancer research [1] [2]. |
Synonyms | ABBV-927 |
Molecular Weight | N/A |
CAS No. | 2226292-20-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Giloralimab 2226292-20-0 ABBV-927 inhibitor inhibit